These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6785437)

  • 1. Other penicillamine-like drugs.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():180-1. PubMed ID: 6785437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The problems of studying disease-remittive agents in RA.
    Huskisson EC
    J Rheumatol Suppl; 1982; 8():201-6. PubMed ID: 6813486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs capable of altering the course of rheumatoid arthritis].
    Trnavski K
    Ter Arkh; 1984; 56(5):19-21. PubMed ID: 6463882
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
    Scott DL; Dawes PT; Fowler PD; Grindulis KA; Shadforth M; Bacon PA
    Q J Med; 1985 Jan; 54(213):49-59. PubMed ID: 3919415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
    Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
    Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of rheumatoid arthritis.
    Huskisson EC
    Int Rehabil Med; 1984; 6(1):i-ii. PubMed ID: 6429077
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 13. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of chrysothiotherapy in the treatment of progressive polyarthritis].
    Vojtísek O; Dostál C; Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):106-12. PubMed ID: 6430770
    [No Abstract]   [Full Text] [Related]  

  • 15. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
    Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
    Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of slow-acting drugs in rheumatoid arthritis.
    Ansell BM
    Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M
    Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.